- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05370313
The Impact of Innovative Tax Proposals on Purchase Patterns
June 2, 2023 updated by: Warren K. Bickel, Virginia Polytechnic Institute and State University
ETM Taxes Study 1: The Impact of Innovative Tax Proposals on Purchase Patterns
This study will investigate the effect of four tax proposals (i.e.
Tobacco Parity, Nicotine-Content, Harm-Reduction, and Modified Risk Tobacco Product-related taxes) on tobacco product purchasing patterns.
Study Overview
Status
Recruiting
Conditions
Detailed Description
This study experimentally examines the effects of largely untried integrated tax proposals.
Four tax proposals will be modeled: Tobacco Parity, Nicotine-Content, Harm-Reduction, and MRTP.
Tobacco products are placed into three tax tiers: high-, medium-, and no-tax, according to the goals of each proposal.
In a within-between subject design (tax proposals between subjects; control condition within subject), cigarette smokers will complete two conditions in the Experimental Tobacco Marketplace, representing one control condition and one of the four tax proposals.
Within each condition, taxes will be increased proportionally across 6 trials (relative to tax tier) to examine how cigarette purchasing, substitution, and poly-tobacco purchasing (i.e., diversity in products purchased) are affected.
Study Type
Interventional
Enrollment (Estimated)
280
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Roberta Freitas Lemos, Ph.D.
- Phone Number: 5405262106
- Email: rflemos@vtc.vt.edu
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14263
- Recruiting
- Roswell Cancer Research Institute
-
Contact:
- Christine Sheffer
-
-
Virginia
-
Roanoke, Virginia, United States, 24016
- Recruiting
- Fralin Biomedical Research Institute
-
Contact:
- Kirstin M Gatchalian
- Email: kmgatch@vt.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- provide informed consent
- provide a breath carbon monoxide sample ≥ 8 ppm,
- be at least 21 years of age (the legal age to purchase tobacco),
- smoke at least 5 cigarettes daily, and
- use other tobacco products less than weekly.
Exclusion Criteria:
- report uncontrolled physical or mental health conditions (e.g., uncontrolled diabetes, high blood pressure, major depressive disorder, etc.),
- use of smoking cessation medications (e.g., nicotine replacement, bupropion, varenicline) in the past 30 days,
- report concrete, immediate plans to alter/quit using their usual tobacco products in the next 30 days,
- be pregnant or lactating, or
- have plans to move out of the area during the experiment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cigarette smokers - Tobacco Parity
Exclusive cigarette smokers will be recruited and will be exposed to the control condition and the Tobacco Parity Tax Condition described in the intervention section.
|
Nicotine/tobacco products available in the Experimental Tobacco Marketplace at market price.
Cigarette taxes increased across trials at the same magnitudes used in the tax conditions.
Tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax.
In this condition, all tobacco products are placed in the high-tax tier while products that do not contain tobacco (e.g., herbal cigarettes and nicotine-free ENDS) are placed in the medium-tax tier.
Nicotine Replacement Therapy products are placed in the no-tax tier.
|
Experimental: Cigarette smokers - Nicotine-Content
Exclusive cigarette smokers will be recruited and will be exposed to the control condition and the Nicotine-Content Tax Condition described in the intervention section.
|
Nicotine/tobacco products available in the Experimental Tobacco Marketplace at market price.
Cigarette taxes increased across trials at the same magnitudes used in the tax conditions.
Tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax.
In this condition, products with greater than 3 mg nicotine per single unit are placed in the high-tax tier, products with 0.6-3.0
mg/unit in the medium-tax tier, and those with 0.5 mg/unit or less in the no-tax tier.
|
Experimental: Cigarette smokers - Harm-Reduction
Exclusive cigarette smokers will be recruited and will be exposed to the control condition and the Harm-ReductionTax Condition described in the intervention section.
|
Nicotine/tobacco products available in the Experimental Tobacco Marketplace at market price.
Cigarette taxes increased across trials at the same magnitudes used in the tax conditions.
Tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax.
In this condition, all combustible products with high abuse liability are placed in the high-tax tier.
All non-combustible products or combustible products with low abuse liability are placed in the medium-tax tier.
Nicotine Replacement Therapy products are placed in the no-tax tier.
|
Experimental: Cigarette smokers - Modified Risk Tobacco Products (MRTP)
Exclusive cigarette smokers will be recruited and will be exposed to the control condition and the MRTP Tax Condition described in the intervention section.
|
Nicotine/tobacco products available in the Experimental Tobacco Marketplace at market price.
Cigarette taxes increased across trials at the same magnitudes used in the tax conditions.
Tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax.
In this condition, all non-MRTP tobacco products are placed in the high-tax tier, MRTPs are placed in the medium-tax tier, and Nicotine Replacement Therapy products are placed in the no-tax tier.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quantity of Tobacco Products Purchased in the High-Tax Tier - Product demand (intensity and elasticity)
Time Frame: 1 day
|
Purchasing of high-tax tier products in the ETM conditions will be fit to a commonly used exponential demand model that quantifies the relationship between the multiplicative tax factor (e.g., 2 times base tax rate) and purchasing of high-tax tier products.
This demand analysis (which assumes a negative association between price and purchasing) will be used in the high-tax tier products because participants will be conventional cigarette smokers and these products (when available) will always be in that tier.
As such, we expect participants to defend their purchase of cigarettes in the high-tax tier under a variety of conditions.
Demand estimates will be obtained for each participant in each tax proposal.
|
1 day
|
Quantity of Tobacco Products Purchased in the Medium- and No-tax tiers - Product substitution (intensity and slope)
Time Frame: 1 day
|
Purchasing of medium- and no-tax products in the ETM conditions will be fit to ordinary least squares regression for each tax tier.
This yields slope measures of each tax tier's product purchasing, wherein more positive slopes indicate greater substitution (i.e., greater increases in purchasing of substitutes as tax magnitudes increase).
Ordinary least squares regression is used here to model purchasing in the medium- and no-tax tier because it is capable of measuring positive slopes, indicative of substitution, and distinguishing these tiers from those that do not show substitution.
In the event this relationship is non-linear, we will consider other relevant models.
|
1 day
|
Poly-tobacco purchasing
Time Frame: 1 day
|
To obtain a measure of poly-tobacco purchasing, entropy (H), a concept borrowed from information theory, will be used.
Entropy is the average level of information in the variable outcomes.
In this proposed use, entropy is minimized for a participant who only purchases one type of product (no inherent information) in a given trial.
Entropy is maximized for participants that purchase equivalent quantities of all products in a given trial.
Entropy permits us to differentiate between participants that purchase mostly cigarettes and a sampling quantity of all other products compared to participants who purchase equivalent quantities of all available products.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Warren K Bickel, Ph.D., Fralin Biomedical Research Institute at VTC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 11, 2023
Primary Completion (Estimated)
September 1, 2024
Study Completion (Estimated)
September 1, 2024
Study Registration Dates
First Submitted
April 29, 2022
First Submitted That Met QC Criteria
May 6, 2022
First Posted (Actual)
May 11, 2022
Study Record Updates
Last Update Posted (Actual)
June 5, 2023
Last Update Submitted That Met QC Criteria
June 2, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VT IRB # 22-433
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The study team will share de-identified data upon request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cigarette Smoking
-
Maastricht University Medical CenterCompletedCigarette Smoking | Cigarette Smoking Toxicity | Smoking BehaviorNetherlands
-
Duke UniversityGeorgetown University; University of MichiganWithdrawnSmoking | Cigarette Smoking | E-cigarette Use
-
Assistance Publique - Hôpitaux de ParisUnknownSmoking Cessation | Smoking, Cigarette | Electronic CigaretteFrance
-
Yale UniversityNational Cancer Institute (NCI)RecruitingSmoking Cessation | Cigarette Smoking | E-Cigarette UseUnited States
-
Medical University of South CarolinaAmerican Cancer Society, Inc.RecruitingSmoking Cessation | Electronic Cigarette Use | Cigarette SmokingUnited States
-
University of St AndrewsNational Health Service, United KingdomUnknownSmoking | Cigarette Smoking | Smoking, Tobacco
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI); New York University; Stanford UniversityRecruitingSmoking | Smoking, Tobacco | Smoking, CigaretteUnited States
-
BIDI VaporCompletedCigarette Smoking | E-cigarette UsePoland
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
Cynthia ConklinNational Institute on Drug Abuse (NIDA)RecruitingSmoking, Cigarette | Smoking BehaviorsUnited States
Clinical Trials on Market Price Condition (control)
-
Virginia Polytechnic Institute and State UniversityMedical University of South Carolina; National Cancer Institute (NCI)CompletedCigarette Smoking | Nicotine VapingUnited States
-
World BankUniversity of California, San Diego; Stanford University; George Washington University and other collaboratorsActive, not recruitingContraception | Contraception Behavior | Contraceptive Usage | Contraceptive Method SwitchingCameroon
-
University of MichiganBill and Melinda Gates Foundation; University of Ghana; Innovations for Poverty... and other collaboratorsCompleted
-
Weill Medical College of Cornell UniversityNational Institute on Aging (NIA); Florida Institute for Human and Machine...CompletedPhysical Activity | Aging | Social IsolationUnited States
-
Weill Medical College of Cornell UniversityNational Institute on Aging (NIA)Completed
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasCompletedColorectal Cancer
-
University of Colorado, BoulderNational Institute of Mental Health (NIMH)CompletedPhysical Activity | Affect
-
Duke UniversityCompletedNicotine DependenceUnited States
-
National Taiwan Normal UniversityCompletedMental FatigueTaiwan
-
University of California, Los AngelesNational Institute of Mental Health (NIMH); University of StellenboschActive, not recruitingDepression | Malnutrition | HIV | Partner Violence | Alcohol Use/AbuseSouth Africa